Literature DB >> 18720005

Severe cholestasis and renal failure associated with the use of the designer steroid Superdrol (methasteron): a case report and literature review.

John Nasr1, Jawad Ahmad.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18720005     DOI: 10.1007/s10620-008-0457-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  13 in total

Review 1.  Abuse of supraphysiologic doses of anabolic steroids.

Authors:  Ryan C W Hall; Richard C W Hall
Journal:  South Med J       Date:  2005-05       Impact factor: 0.954

2.  Cholestatic jaundice and IgA nephropathy induced by OTC muscle building agent superdrol.

Authors:  Beata Jasiurkowski; Jaya Raj; David Wisinger; Richard Carlson; Lixian Zou; Abdul Nadir
Journal:  Am J Gastroenterol       Date:  2006-09-04       Impact factor: 10.864

3.  Peliosis hepatis associated with androgenic-anabolic steroid therapy. A severe form of hepatic injury.

Authors:  S A Bagheri; J L Boyer
Journal:  Ann Intern Med       Date:  1974-11       Impact factor: 25.391

Review 4.  Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature.

Authors:  L Socas; M Zumbado; O Pérez-Luzardo; A Ramos; C Pérez; J R Hernández; L D Boada
Journal:  Br J Sports Med       Date:  2005-05       Impact factor: 13.800

5.  Prevalence and risk factors for anabolic-androgenic steroid abuse in Australian high school students.

Authors:  D J Handelsman; L Gupta
Journal:  Int J Androl       Date:  1997-06

6.  Anabolic androgenic steroids: a survey of 500 users.

Authors:  Andrew B Parkinson; Nick A Evans
Journal:  Med Sci Sports Exerc       Date:  2006-04       Impact factor: 5.411

Review 7.  Effects of androgenic-anabolic steroids in athletes.

Authors:  Fred Hartgens; Harm Kuipers
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

8.  Androgenic/Anabolic steroid-induced toxic hepatitis.

Authors:  Davor Stimac; Sandra Milić; Renata Dobrila Dintinjana; Drazen Kovac; Smiljana Ristić
Journal:  J Clin Gastroenterol       Date:  2002-10       Impact factor: 3.062

Review 9.  Multiple hepatic adenomas after long-term therapy with testosterone enanthate. Review of the literature.

Authors:  D Carrasco; M Prieto; L Pallardó; J L Moll; J M Cruz; C Muñoz; J Berenguer
Journal:  J Hepatol       Date:  1985       Impact factor: 25.083

Review 10.  The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety.

Authors:  Rhonda Orr; Maria Fiatarone Singh
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more
  7 in total

1.  Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids.

Authors:  Nawed Deshmukh; Andrea Petróczi; James Barker; Andrea D Székely; Iltaf Hussain; Declan P Naughton
Journal:  Subst Abuse Treat Prev Policy       Date:  2010-04-29

Review 2.  Acute kidney injury due to anabolic steroid and vitamin supplement abuse: report of two cases and a literature review.

Authors:  Elizabeth F Daher; Geraldo B Silva Júnior; Anaiara L Queiroz; Lysiane M A Ramos; Silvia Q Santos; Dulce M S Barreto; Antonio Augusto C Guimarães; Célio A Barbosa; Luciano M Franco; Régia M S V Patrocínio
Journal:  Int Urol Nephrol       Date:  2009-04-23       Impact factor: 2.370

3.  Cholestatic jaundice, acute kidney injury and acute pancreatitis secondary to the recreational use of methandrostenolone: a case report.

Authors:  Greg A Rosenfeld; Albert Chang; Michael Poulin; Peter Kwan; Eric Yoshida
Journal:  J Med Case Rep       Date:  2011-04-06

Review 4.  Neurotoxicity by synthetic androgen steroids: oxidative stress, apoptosis, and neuropathology: A review.

Authors:  Cristoforo Pomara; Margherita Neri; Stefania Bello; Carmela Fiore; Irene Riezzo; Emanuela Turillazzi
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

5.  Structural transformation of methasterone with Cunninghamella blakesleeana and Macrophomina phaseolina.

Authors:  Muhammad Aamer; Mahwish Siddiqui; Almas Jabeen; Rimsha Irshad; Farooq-Ahmad Khan; M Iqbal Choudhary; Yan Wang
Journal:  RSC Adv       Date:  2022-03-25       Impact factor: 3.361

Review 6.  Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States.

Authors:  Mark I Avigan; Robert P Mozersky; Leonard B Seeff
Journal:  Int J Mol Sci       Date:  2016-03-03       Impact factor: 5.923

Review 7.  Treatments for people who use anabolic androgenic steroids: a scoping review.

Authors:  Geoff Bates; Marie-Claire Van Hout; Joseph Tay Wee Teck; Jim McVeigh
Journal:  Harm Reduct J       Date:  2019-12-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.